These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 27180882)
1. Elevated endocan concentration is associated with coronary slow flow. Ye MF; Zhao ZW; Luo YK; Dong XF; Yan YM Scand J Clin Lab Invest; 2016 Sep; 76(5):345-8. PubMed ID: 27180882 [TBL] [Abstract][Full Text] [Related]
2. [Can biomarkers help us to understand the pathogenesis of coronary slow flow? Endocan and omentin-I in slow coronary flow phenomenon]. Sığırcı S; Sarıkaya R; Keskin K; Yıldız SS; Pilten Güzel S; Çetinkal G; Önur İ; Kılıçkesmez KO Turk Kardiyol Dern Ars; 2019 Jun; 47(4):251-257. PubMed ID: 31219439 [TBL] [Abstract][Full Text] [Related]
3. The Relationship Between Serum Endocan Levels With the Presence of Slow Coronary Flow: A Cross-Sectional Study. Kundi H; Gok M; Kiziltunc E; Topcuoglu C; Cetin M; Cicekcioglu H; Ugurlu B; Ulusoy FV Clin Appl Thromb Hemost; 2017 Jul; 23(5):472-477. PubMed ID: 26607436 [TBL] [Abstract][Full Text] [Related]
4. Endocan may predict the presence of coronary slow flow and coronary artery disease. Efe MM; Akyüz A; Aydın C; Demirkıran A; Alpsoy Ş Rev Assoc Med Bras (1992); 2024; 70(8):e20240515. PubMed ID: 39230149 [TBL] [Abstract][Full Text] [Related]
5. Elevated Human Endothelial Cell-Specific Molecule-1 Level and Its Association With Coronary Artery Disease in Patients With Hypertension. Xiong C; Zhao ZW; Chen ZY; Wu LZ; Luo YK; Hu FD; Lin CG; Chen LL J Investig Med; 2015 Oct; 63(7):867-70. PubMed ID: 26200037 [TBL] [Abstract][Full Text] [Related]
6. Serum endocan levels are correlated with the presence and severity of coronary artery disease in patients with hypertension. Wang XS; Yang W; Luo T; Wang JM; Jing YY Genet Test Mol Biomarkers; 2015 Mar; 19(3):124-7. PubMed ID: 25588082 [TBL] [Abstract][Full Text] [Related]
7. Serum Endocan Level and the Severity of Coronary Artery Disease: A Pilot Study. Kose M; Emet S; Akpinar TS; Kocaaga M; Cakmak R; Akarsu M; Yuruyen G; Arman Y; Tukek T Angiology; 2015 Sep; 66(8):727-31. PubMed ID: 25168956 [TBL] [Abstract][Full Text] [Related]
8. Endocan: a novel biomarker associated with well-developed coronary collateral circulation in patients with stable angina and chronic total occlusion. Emet S; Elitok A; Onur I; Kocaaga M; Bilge AK; Oflaz H; Umman B; Oncul A; Bugra Z; Adalet K; Mercanoglu F J Thromb Thrombolysis; 2017 Jan; 43(1):60-67. PubMed ID: 27638814 [TBL] [Abstract][Full Text] [Related]
9. Endocan Levels and Coronary Collateral Circulation in Stable Angina Pectoris: A Pilot Study. Gok M; Kundi H; Kiziltunc E; Topcuoglu C; Ornek E Angiology; 2018 Jan; 69(1):43-48. PubMed ID: 28393589 [TBL] [Abstract][Full Text] [Related]
10. Human Endothelial Cell-Specific Molecule-1 (Endocan) and Coronary Artery Disease and Microvascular Angina. Çimen T; Efe TH; Akyel A; Sunman H; Algül E; Şahan HF; Erden G; Özdemir Ş; Alay EF; Doğan M; Yeter E Angiology; 2016 Oct; 67(9):846-53. PubMed ID: 26744512 [TBL] [Abstract][Full Text] [Related]
11. Plasma Endocan Levels in Patients With Isolated Coronary Artery Ectasia. Turan T; Akyuz AR; Aykan AC; Kul S; Cirakoglu OF; Aslan AO; Gul I; Uçar U; Demir S; Celik S Angiology; 2016 Nov; 67(10):932-936. PubMed ID: 26980772 [TBL] [Abstract][Full Text] [Related]
12. The relationship between coronary slow flow phenomenon and urotensin-II: A prospective and controlled study. Zengin H; Erbay AR; Okuyucu A; Alaçam H; Yüksel S; Meriç M; Soylu K; Gedikli Ö; Murat N; Gülel O; Demircan S; Akın F; Yılmaz Ö; Şahin M Anatol J Cardiol; 2015 Jun; 15(6):475-9. PubMed ID: 25430414 [TBL] [Abstract][Full Text] [Related]
13. Serum levels of endocan correlate with the presence and severity of pre-eclampsia. Cakmak M; Yilmaz H; Bağlar E; Darcin T; Inan O; Aktas A; Celik HT; Ozdemir O; Atalay CR; Akcay A Clin Exp Hypertens; 2016; 38(2):137-42. PubMed ID: 26418319 [TBL] [Abstract][Full Text] [Related]
14. Admission Endocan Level may be a Useful Predictor for In-Hospital Mortality and Coronary Severity Index in Patients With ST-Segment Elevation Myocardial Infarction. Kundi H; Balun A; Cicekcioglu H; Karayigit O; Topcuoglu C; Kilinckaya MF; Kiziltunc E; Cetin M; Ornek E Angiology; 2017 Jan; 68(1):46-51. PubMed ID: 27178721 [TBL] [Abstract][Full Text] [Related]
15. The relation between coronary flow rate, plasma endothelin-1 concentrations, and clinical characteristics in patients with normal coronary arteries. Celebi H; Catakoglu AB; Kurtoglu H; Sener M; Hanavdelogullari R; Demiroglu C; Aytekin V; Aytekin S Cardiovasc Revasc Med; 2008; 9(3):144-8. PubMed ID: 18606377 [TBL] [Abstract][Full Text] [Related]
16. The Association Between Endocan Levels and Subclinical Atherosclerosis in Patients With Type 2 Diabetes Mellitus. Lv Y; Zhang Y; Shi W; Liu J; Li Y; Zhou Z; He Q; Wei S; Liu J; Quan J Am J Med Sci; 2017 May; 353(5):433-438. PubMed ID: 28502328 [TBL] [Abstract][Full Text] [Related]
17. Serum Endothelial Cell-Specific Molecule 1 (Endocan) Levels in Patients With Acute Myocardial Infarction and Its Clinical Significance. Qiu CR; Fu Q; Sui J; Zhang Q; Wei P; Wu Y; Zhu K; Lu Y; Zong B Angiology; 2017 Apr; 68(4):354-359. PubMed ID: 27225701 [TBL] [Abstract][Full Text] [Related]
18. Documentation of impaired coronary blood flow by TIMI frame count method in patients with atrial fibrillation. Luo C; Wu X; Huang Z; Du Z; Hao Y; Hu C; Huang Y; Gao X Int J Cardiol; 2013 Aug; 167(4):1176-80. PubMed ID: 22483250 [TBL] [Abstract][Full Text] [Related]
19. Elevated endocan levels and its association with clinical severity in Stevens-Johnson Syndrome and toxic epidermal necrolysis. Syed D; Iqbal O; Mosier M; Mitchell R; Hoppensteadt D; Bouchard C; Fareed J; Gamelli R Int Angiol; 2015 Oct; 34(5):483-8. PubMed ID: 25394955 [TBL] [Abstract][Full Text] [Related]